BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35341821)

  • 21. Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma.
    Abdulamir AS; Hafidh RR; Abu Bakar F; Abbas K
    Am J Otolaryngol; 2010; 31(6):410-7. PubMed ID: 20015794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
    Liu S; Liu W; Zhao D; Zhang Y; Zhao Z; Luo B
    Oncol Res Treat; 2019; 42(11):572-579. PubMed ID: 31522169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
    Zhou T; Yang DW; He YQ; Xue WQ; Liao Y; Zheng MQ; Jia YJ; Yuan LL; Zhang WL; Zeng YX; Jia WH
    Cancer Med; 2019 Aug; 8(10):4852-4866. PubMed ID: 31241250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
    Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
    Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic landscape of Epstein-Barr virus in familial nasopharyngeal carcinoma.
    Zhang WL; Zhang JB; Wang TM; Wu YX; He YQ; Xue WQ; Liao Y; Deng CM; Li DH; Wu ZY; Yang DW; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Jia WH
    J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35349400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
    Tsang CM; Tsao SW
    Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.
    Ayee R; Ofori MEO; Tagoe EA; Languon S; Searyoh K; Armooh L; Bilson-Amoah E; Baidoo K; Kitcher E; Wright E; Quaye O
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32708700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation.
    Xu M; Feng R; Liu Z; Zhou X; Chen Y; Cao Y; Valeri L; Li Z; Liu Z; Cao SM; Liu Q; Xie SH; Chang ET; Jia WH; Shen J; Yao Y; Cai YL; Zheng Y; Zhang Z; Huang G; Ernberg I; Tang M; Ye W; Adami HO; Zeng YX; Lin X
    Cell Genom; 2024 Feb; 4(2):100474. PubMed ID: 38359790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.
    Guo X; Johnson RC; Deng H; Liao J; Guan L; Nelson GW; Tang M; Zheng Y; de The G; O'Brien SJ; Winkler CA; Zeng Y
    Int J Cancer; 2009 Jun; 124(12):2942-7. PubMed ID: 19296536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Yu KJ; Hsu WL; Chiang CJ; Chen TC; Liu Z; Lou PJ; Diehl S; Goldstein AM; Chen CJ; Wang CP; Hildesheim A
    Cancer; 2021 Nov; 127(22):4171-4176. PubMed ID: 34324707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
    J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes can increase the prevalence of EBV infection and worsen the prognosis of nasopharyngeal carcinoma.
    Midorikawa S; Mizukami H; Kudoh K; Takeuchi Y; Sasaki T; Kushibiki H; Wang Z; Itakura Y; Murakami K; Kudo N; Nagaki T; Wakasa T; Nakamura Y; Matsubara A
    Pathology; 2024 Feb; 56(1):65-74. PubMed ID: 38071160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases.
    Lam WKJ; Jiang P; Chan KCA; Peng W; Shang H; Heung MMS; Cheng SH; Zhang H; Tse OYO; Raghupathy R; Ma BBY; Hui EP; Chan ATC; Woo JKS; Chiu RWK; Lo YMD
    Nat Commun; 2019 Jul; 10(1):3256. PubMed ID: 31332191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
    Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
    Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histocompatibility locus antigens regions contribute to the ethnicity bias of Epstein-Barr virus-associated nasopharyngeal carcinoma in higher-incidence populations.
    Roy Chattopadhyay N; Chakrabarti S; Chatterjee K; Deb Roy S; Kumar Sahu S; Reddy RR; Das P; Bijay Kanrar B; Kumar Das A; Tsering S; Puii Z; Zomawia E; Singh YI; Suryawanshi A; Choudhuri T
    Scand J Immunol; 2019 Oct; 90(4):e12796. PubMed ID: 31145476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
    Baizig NM; Morand P; Seigneurin JM; Boussen H; Fourati A; Gritli S; Oueslati Z; Touati S; Gamoudi A; Ben Abdallah M; El May M; El May A
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1005-11. PubMed ID: 21805179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidome-wide association analysis of Epstein-Barr virus identifies epitope repertoires associated with nasopharyngeal carcinoma.
    Deng CM; Wang TM; He YQ; Zhang WL; Xue WQ; Li DH; Yang DW; Wang QL; Liao Y; Diao H; Jiang CT; Zhang JB; Yuan LL; Chen XY; Zhou T; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Xu M; Zeng MS; Feng L; Jia WH
    J Med Virol; 2023 Jun; 95(6):e28860. PubMed ID: 37310118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
    Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
    Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.